Andrew Kennedy

No ORCID on file · 3 papers in corpus
lab-animal 2025
TET3 is a common epigenetic immunomodulator of pathogenic macrophages
The Journal of clinical investigation ·doi:10.1172/JCI194879

Through a combination of single-cell/single-nucleus RNA-Seq (sc/snRNA-Seq) data analysis, immunohistochemistry, and primary macrophage studies, we have identified pathogenic macrophages characterized by Tet methylcytosine dioxygenase 3 (TET…

2012
A multi-centre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia
·doi:10.1186/isrctn85619876
nonrandomized-trial 2003
A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia
Health technology assessment (Winchester, England) ·doi:10.3310/hta7080

T he NHS R&D Health Technology Assessment (HTA) Programme was set up in 1993 to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for th…